alder biopharmaceuticals ceo: mastering migraines | mad money | cnbc
Published 6 years ago • 824 plays • Length 5:55Download video MP4
Download video MP3
Similar videos
-
5:45
alder biopharmaceuticals ceo: addressing chronic migraines | mad money | cnbc
-
7:30
alder biopharmaceuticals ceo: is the tide turning? | mad money | cnbc
-
6:09
alder biopharmaceuticals ceo: a stock on fire | mad money | cnbc
-
6:06
cara therapeutics ceo: battling opioids | mad money | cnbc
-
6:30
radius health ceo: biotech bliss ahead? | mad money | cnbc
-
6:14
intarcia therapeutics ceo: holy grail of disease treatment | mad money | cnbc
-
6:27
seres therapeutics ceo: banking on bacteria | mad money | cnbc
-
2:34
biohaven pharmaceutical ceo on efforts to prevent migraines with oral cgrp
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
7:14
8 struggles of being a highly intelligent person
-
8:02
avita medical ceo: our tech revolutionizes care for burn patients
-
5:36
pain & addiction - biodelivery sciences | mad money | cnbc
-
7:17
biomarin ceo: rare treatments, high costs | mad money | cnbc
-
6:01
biomarin pharmaceutical ceo: close to a cure? | mad money | cnbc
-
6:00
biotelemetry ceo: cloud-based health | mad money | cnbc
-
2:29
biohaven ceo on 'monumental approval' of migraine drug
-
4:43
acorda therapeutics ceo: high-powered biotech | mad money | cnbc
-
7:02
sage therapeutics ceo: challenging conventional wisdom | mad money | cnbc
-
6:57
biomarin pharmaceutical ceo: substantial profits ahead | mad money | cnbc
-
6:04
radius health ceo robert ward: biotech bliss | mad money | cnbc
-
7:06
allergan ceo brent saunders: inside the massive deal with pfizer | mad money | cnbc
-
6:19
seres therapeutics ceo: fighting the biotech decline | mad money | cnbc